FDA Inspection
Grifols Therapeutics LLCGrifols Therapeutics LLC – FDA Inspection, Dec 13, 2018
Record Details
This FDA Inspection record concerns Grifols Therapeutics LLC, with an inspection on December 13, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · a8c4df93-a1d3-415f-a6ee-5067a6f6675c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1079999
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Grifols Therapeutics LLC
8| Date | Classification | Office | Project area |
|---|---|---|---|
| February 5, 2026 | Not classified | Atlanta District Office | Blood and Blood Products |
| September 1, 2023 | Not classified | Atlanta District Office | |
| May 6, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| February 10, 2017 | Not classified | Atlanta District Office | |
| October 21, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Grifols Therapeutics LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.